Hansa Biopharma AB - Company Profile
Powered by 
All the sales intelligence you need on Hansa Biopharma AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Hansa Biopharma AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Hansa Biopharma AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Hansa Biopharma AB patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| CO2022018347A2 | Application | Cisteína proteasa | A61K38/4873; C12N15/70; C12N9/52; C12Y304/22 | February 27, 2023 |
| BR112022023545A2 | Application | POLIPEPTÍDEO COM ATIVIDADE DE CISTEÍNA PROTEASE DE IGG, POLINUCLEOTÍDEO, VETOR DE EXPRESSÃO, CÉLULA HOSPEDEIRA, COMPOSIÇÃO E MÉTODOS PARA A PREVENÇÃO OU TRATAMENTO DE UMA DOENÇA OU CONDIÇÃO E PARA A CLIVAGEM DE IGG EX VIVO | C12N9/52; C12Y304/22 | January 17, 2023 |
| EP4114369A1 | Application | KONDITIONIERUNGSPLAN FÜR TRANSPLANTAT | A61K35/28; A61K38/05; A61K38/47; A61K38/4873; A61K39/395; A61P35/00; A61P37/06; C07K16/00; C07K16/2803; C07K16/2833; C07K2317/52; C07K2317/54; C07K2317/73; C07K2317/734; C12Y302/01096; C12Y302/01169; C12Y304/2201 | January 11, 2023 |
| EP4108768A1 | Application | CYSTEINPROTEASE | A61K38/00; A61K38/48; A61P1/16; A61P19/02; A61P25/00; A61P29/00; A61P3/10; A61P31/14; A61P35/00; A61P35/02; A61P37/06; A61P7/06; A61P9/00; C12N9/52; C12N9/54; Y02A50/30 | December 28, 2022 |
| EP4103947A1 | Application | IMMUNOGLOBULIN-NACHWEIS UND ZUGEHÖRIGE THERAPIEN | G01N2333/96466; G01N33/686 | December 21, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer